UBE3A and Angelman syndrome: UBE3A is well known for its oncogenic role in the proteasomal degradation of P53 upon binding to the human papillomavirus E6 protein (Yamamoto et al., 1997); however, variants of the UBE3A gene are also associated with the neurodevelopmental disease Angelman's syndrome (Kishino et al., 1997).